Ovarian Cancer Trial, Recruiting NCT06907771 Sponsor: University Hospital, Strasbourg, France Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06907771
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who had surgery at the HUS (a hospital) between January 1, 2010 and December 31, 2022
  • People who underwent a type of surgery aimed at removing as much cancer as possible (either as the first treatment or after initial chemotherapy)
  • People diagnosed with an advanced stage (stage FIGO IIIC or IV) of a specific type of ovarian cancer called high-grade serous carcinoma

Who may not be able to join:

  • People who have previously stated they do not want their personal data used for scientific research purposes
  • People with a different type of ovarian cancer (other than high-grade serous carcinoma)
  • People whose cancer was diagnosed at an earlier stage (FIGO stages I, II, IIIA, or IIIB) (confirm with trial site)
  • People who underwent a specific type of closing or completion surgery (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 3 88 12 75 10

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 April 2024
Est. completion
22 December 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Study of progression-free survival at 36 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov